Axsome Therapeutics, Inc. Annual Operating Income (Loss) in USD from 2014 to 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Axsome Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2014 to 2024.
  • Axsome Therapeutics, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$72.6M, a 26.1% increase year-over-year.
  • Axsome Therapeutics, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$281M, a 21% decline year-over-year.
  • Axsome Therapeutics, Inc. annual Operating Income (Loss) for 2024 was -$281M, a 21% decline from 2023.
  • Axsome Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$232M, a 28.9% decline from 2022.
  • Axsome Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$180M, a 44.2% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$281M -$48.7M -21% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-18
2023 -$232M -$52M -28.9% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-18
2022 -$180M -$55.1M -44.2% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-18
2021 -$125M -$25.6M -25.8% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-23
2020 -$99.1M -$31.9M -47.4% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 -$67.2M -$34.4M -105% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 -$32.8M -$5.68M -20.9% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 -$27.2M +$379K +1.38% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-12
2016 -$27.5M -$18.3M -200% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-15
2015 -$9.2M -$3.52M -62.1% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-07
2014 -$5.67M Jan 1, 2014 Dec 31, 2014 10-K 2017-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.